Tylenol debuts 2 new pain products
Kenvue is showcasing new topical Tylenol Precise Pain Relieving Cream—the first U.S. product launch from Kenvue since it became a publicly traded company—during the PAINWeek Conference 2023 on Sept. 5-8 at The Cosmopolitan in Las Vegas, Nev.
Kenvue also will feature another product newly launched this year, Motrin Dual Action with Tylenol, a fixed combination pill (containing 250 mg of acetaminophen and 125 mg of ibuprofen in each tablet) that provides dosing that supports up to 8 hours of pain relief compared with dosing provided by Tylenol Extra Strength or Motrin single ingredient products that can provide up to 6 hours of relief.
Both of these products come in response to consumer insights collected by Tylenol.
[Read more: Products to Watch: HRG’s top 5 faves from July 2022]